MedTrace Logo

A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101

NCT01668199 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2012-08-17

No results posted yet for this study

Summary

A study to investigate the mass balance recovery and pharmacokinetics of 14C TZP-101.

Conditions

  • Postoperative Ileus

Interventions

DRUG

TZP-101

Sponsors & Collaborators

Principal Investigators

  • Philip Evans, MD · Quotient Clinical, Mere Way, Ruddlington Fields, Nottingham

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-02-29
Completion
2012-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01668199 on ClinicalTrials.gov